Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe Cohort.

Pediatric dermatology·2026
Same author

Concomitant HS and PsO: Disease severity and inflammatory phenotypes during biologic therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

The enigma of hidradenitis suppurativa: Michelangelo's "Awakening Slave".

The Journal of investigative dermatology·2026
Same author

Prospective single-center study on efficacy and tolerability of ustekinumab biosimilars in moderate-to-severe psoriasis: short term results.

Italian journal of dermatology and venereology·2026
Same author

Treatment-associated phenotype switching between psoriasis and atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' Lives.

Dermatology practical & conceptual·2026

Related Experiment Video

Updated: Jun 13, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Psoriasis and body mass index.

Jana Hercogová1, Frederica Ricceri, Lara Tripo

  • 1Department of Dermatological Sciences, University of Florence, Florence, Italy.

Dermatologic Therapy
|April 27, 2010
PubMed
Summary

Increased adiposity and obesity are strongly linked to psoriasis incidence and severity. Body Mass Index (BMI) analysis is crucial for tailoring effective systemic treatments for psoriasis patients.

Related Experiment Videos

Last Updated: Jun 13, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Area of Science:

  • Dermatology and Metabolic Health

Background:

  • Obesity and increased adiposity show a strong association with psoriasis.
  • Psoriasis is linked to metabolic syndrome components like type 2 diabetes, hypertension, and hyperlipidemia.

Purpose of the Study:

  • To explore the relationship between obesity, Body Mass Index (BMI), and psoriasis.
  • To understand how obesity influences psoriasis activity and treatment response.

Main Methods:

  • Analysis of Body Mass Index (BMI) as a measure of weight-for-height.
  • Review of existing literature associating obesity with psoriasis and related comorbidities.

Main Results:

  • Obesity is associated with higher psoriasis incidence and activity.
  • Obesity can impact the choice and effectiveness of systemic psoriasis treatments.

Conclusions:

  • Dermatologists must consider patient BMI and obesity-related conditions when selecting psoriasis therapies.
  • Integrating BMI assessment into clinical practice can optimize psoriasis management.